Tokai Pharmaceuticals To Present At Upcoming Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced that it will present at two upcoming conferences:
•Jodie Morrison, President and Chief Executive Officer, will participate in Cancer Advance Boston as part of a panel titled “Biomarkers and Companion Diagnostics: What’s Novel?” The panel will take place at Harvard Medical School on Tuesday, April 14, 2015 at 12:20pm ET.
Help employers find you! Check out all the jobs and post your resume.
•Jodie Morrison, President and Chief Executive Officer, will participate in Cancer Advance Boston as part of a panel titled “Biomarkers and Companion Diagnostics: What’s Novel?” The panel will take place at Harvard Medical School on Tuesday, April 14, 2015 at 12:20pm ET.
Help employers find you! Check out all the jobs and post your resume.